Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors

NCT01971489 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Adult Solid Neoplasm
Recurrent Non-Small Cell Lung Carcinoma
Stage IIIA Non-Small Cell Lung Cancer
Stage IIIB Non-Small Cell Lung Cancer
Stage IV Non-Small Cell Lung Cancer

Interventions

DRUG: Buparlisib
DRUG: Cisplatin
DRUG: Gemcitabine Hydrochloride
OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study
OTHER: Questionnaire Administration

Sponsor

Roswell Park Cancer Institute